18 results on '"Jean-François Tessier"'
Search Results
2. Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study)
- Author
-
Marjolaine Giroux, Nicolas Bouchard, Anik Henderson, Lesly Lam, Van Anh Sylvie Tran, Denis Projean, Jean-François Tessier, Laurence Lepage, Paul Gavra, Georges Ouellet, Michel Vallée, and Jean-Philippe Lafrance
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Background and Objectives: There is a renewed interest in the successful use of aminoglycosides due to increasing resistance in gram-negative infections. Few studies to date have examined the pharmacokinetics (PK) of intradialytic infusions of tobramycin. This study sought to characterize the pharmacokinetic profile of intradialytically administered tobramycin in infected patients receiving chronic intermittent hemodialysis and to determine whether it is possible to achieve favorable PK targets. Design, Setting, Participants, and Measurements: In this prospective pharmacokinetic study, a single dose (5 mg/kg) of tobramycin was administered intradialytically to 11 noncritically ill patients undergoing chronic intermittent hemodialysis. Blood samples were collected at selected time to determine tobramycin serum concentrations. The PK analysis was performed using Phoenix™ NLME. The efficacy exposure outcome for nonsevere gram-negative infections sensitive to tobramycin with a minimum inhibitory concentration ≤1 were maximum concentration (Cmax ≥ 10 mg/L) and area under the curve (AUC24 h > 30 mg⋅h/L). For toxicity, the goal was to identify plasma trough concentrations
- Published
- 2021
- Full Text
- View/download PDF
3. Environmental exposure to pesticides and respiratory health
- Author
-
Ali Mamane, Chantal Raherison, Jean-François Tessier, Isabelle Baldi, and Ghislaine Bouvier
- Subjects
Diseases of the respiratory system ,RC705-779 - Abstract
Respiratory effects of environmental exposure to pesticides are debated. Here we aimed to review epidemiological studies published up until 2013, using the PubMed database. 20 studies dealing with respiratory health and non-occupational pesticide exposure were identified, 14 carried out on children and six on adults. In four out of nine studies in children with biological measurements, mothers' dichlorodiphenyldichloroethylene (DDE) blood levels during pregnancy were associated with asthma and wheezing in young children. An association was also found between permethrin in indoor air during pregnancy and wheezing in children. A significant association between asthma and DDE measured in children's blood (aged 7–10 years) was observed in one study. However, in three studies, no association was found between asthma or respiratory infections in children and pesticide levels in breast milk and/or infant blood. Lastly, in three out of four studies where post-natal pesticide exposure of children was assessed by parental questionnaire an association with respiratory symptoms was found. Results of the fewer studies on pesticide environmental exposure and respiratory health of adults were much less conclusive: indeed, the associations observed were weak and often not significant. In conclusion, further studies are needed to confirm whether there is a respiratory risk associated with environmental exposure to pesticides.
- Published
- 2015
- Full Text
- View/download PDF
4. Occupational exposure to pesticides and respiratory health
- Author
-
Ali Mamane, Isabelle Baldi, Jean-François Tessier, Chantal Raherison, and Ghislaine Bouvier
- Subjects
Diseases of the respiratory system ,RC705-779 - Abstract
This article aims to review the available literature regarding the link between occupational exposure to pesticides and respiratory symptoms or diseases. Identification of epidemiological studies was performed using PubMed. 41 articles were included, 36 regarding agricultural workers and five regarding industry workers. Among the 15 cross-sectional studies focusing on respiratory symptoms and agricultural pesticide exposure, 12 found significant associations with chronic cough, wheeze, dyspnoea, breathlessness or chest tightness. All four studies on asthma found a relationship with occupational exposure, as did all three studies on chronic bronchitis. The four studies that performed spirometry reported impaired respiratory function linked to pesticide exposure, suggestive of either obstructive or restrictive syndrome according to the chemical class of pesticide. 12 papers reported results from cohort studies. Three out of nine found a significant relationship with increased risk of wheeze, five out of nine with asthma and three out of three with chronic bronchitis. In workers employed in pesticide production, elevated risks of chronic obstructive pulmonary disease (two studies out of three) and impaired respiratory function suggestive of an obstructive syndrome (two studies out of two) were reported. In conclusion, this article suggests that occupational exposure to pesticides is associated with an increased risk of respiratory symptoms, asthma and chronic bronchitis, but the causal relationship is still under debate.
- Published
- 2015
- Full Text
- View/download PDF
5. sj-pdf-1-cjk-10.1177_2054358120987061 – Supplemental material for Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study)
- Author
-
Giroux, Marjolaine, Bouchard, Nicolas, Anik Henderson, Lam, Lesly, Tran, Van Anh Sylvie, Projean, Denis, Jean-François Tessier, Lepage, Laurence, Gavra, Paul, Ouellet, Georges, Vallée, Michel, and Jean-Philippe Lafrance
- Subjects
Medicine - Abstract
Supplemental material, sj-pdf-1-cjk-10.1177_2054358120987061 for Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study) by Marjolaine Giroux, Nicolas Bouchard, Anik Henderson, Lesly Lam, Van Anh Sylvie Tran, Denis Projean, Jean-François Tessier, Laurence Lepage, Paul Gavra, Georges Ouellet, Michel Vallée and Jean-Philippe Lafrance in Canadian Journal of Kidney Health and Disease
- Published
- 2021
- Full Text
- View/download PDF
6. Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry
- Author
-
George Zhanel, Melanie Baxter, Maggie Wong, Yazdan Mirzanejad, Anna Lee, Rita Dhami, Justin Kosar, Denise Werry, Neal Irfan, Jean-Francois Tessier, Gabriel Girourd, Carlo Tascini, Teagen Rolf von den Baumen, Andrew Walkty, and James A. Karlowsky
- Subjects
Fosfomycin ,CLEAR ,Efficacy ,Bacteremia ,Pneumonia ,Adverse effects ,Microbiology ,QR1-502 - Abstract
ABSTRACT: Objectives: Data on the use of intravenous (IV) fosfomycin in Canada are limited. Using data captured by the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry, we report the use of IV fosfomycin in Canadian patients. Methods: The CLEAR registry uses the web-based data management program, REDCapTM (https://rcsurvey.radyfhs.umanitoba.ca/surveys/?s=F7JXNDFXEF) to facilitate clinicians’ entering of details associated with their clinical experiences using IV fosfomycin. Results: Data were available for 59 patients treated with IV fosfomycin. The most common infections treated were: bacteraemia or sepsis (25.4% of patients), complicated urinary tract infection (20.3%), ventilator-associated bacterial pneumonia (18.6%), and hospital-acquired pneumonia (13.6%). IV fosfomycin was used to treat Gram-negative (88.1%) and Gram-positive (10.2%) infections. The most common pathogens treated were carbapenem-resistant Enterobacterales (44.1%), multidrug-resistant Pseudomonas aeruginosa (18.6%), vancomycin-resistant Enterococcus faecium (5.1%), and methicillin-resistant Staphylococcus aureus (3.4%). IV fosfomycin was primarily used due to resistance to initially prescribed therapies (69.5%), frequently in combination with other agents (86.4%). Microbiological success (eradication/presumed eradication) occurred in 77.4% of patients, and clinical success (clinical cure/improvement) occurred in 62.5%. Overall, 15.3% of patients died because of their infection. Adverse effects were not documented in 73.1% of patients, and no patient discontinued therapy because of an adverse effect. Conclusions: In Canada, IV fosfomycin is used primarily as directed therapy to treat a variety of severe infections caused by Gram-negative and Gram-positive bacteria. It is primarily used in patients infected with bacteria resistant to other agents and as part of combination therapy. Its use is associated with relatively high microbiological and clinical cure rates, and it has an excellent safety profile.
- Published
- 2023
- Full Text
- View/download PDF
7. Lower-Limb Power cannot be Estimated Accurately from Vertical Jump Tests
- Author
-
Fabien A. Basset, Martin Simoneau, Normand Teasdale, and Jean-François Tessier
- Subjects
validity ,business.industry ,Physical Therapy, Sports Therapy and Rehabilitation ,030229 sport sciences ,Kinematics ,Letter To The Editor ,Outcome (probability) ,Power (physics) ,03 medical and health sciences ,Vertical jump ,0302 clinical medicine ,Countermovement ,minimal difference ,Section I – Kinesiology ,Physiology (medical) ,Statistics ,Countermovement jump ,Jump ,Medicine ,Ground reaction force ,business ,force ,030217 neurology & neurosurgery ,Simulation - Abstract
The countermovement jump test is often adopted to monitor lower-limb power of an individual. Despite several studies on the validity of this test, there is still a need to determine the minimal difference needed to be confident that a difference in power between two individuals is present or that a true change in the performance of an individual has occurred. In this study, power was measured from ground reaction forces and compared to that obtained from predictive equations for two groups of subjects (67 trained and 20 highly trained individuals). The height of each jump was determined with kinematic techniques. The main outcome is a large discrepancy between power calculated from ground reaction forces and that calculated from predictive equations. For the trained group, the R-square value between power and predicted power was 0.53 and the minimal difference to consider that two individuals were different was 821.7 W. For the highly trained individuals, a much larger R-square value was obtained (0.94). Despite this, the minimal difference to consider that two individuals were different was still large (689.3 W). The large minimal differences obtained raise serious concerns about using countermovement jumps for appraisal and monitoring of lower-limb power of an individual.
- Published
- 2013
8. Increase in the Risk of Respiratory Disorders in Adults and Children Related to Crop-Growing in Niger
- Author
-
Ali, Mamane, Jean-François, Tessier, Ghislaine, Bouvier, Roger, Salamon, Pierre, Lebailly, Chantal, Raherison, and Isabelle, Baldi
- Subjects
Adult ,Male ,Adolescent ,Article Subject ,lcsh:Public aspects of medicine ,Respiratory Tract Diseases ,Agriculture ,lcsh:RA1-1270 ,Middle Aged ,Young Adult ,Cross-Sectional Studies ,Risk Factors ,Multivariate Analysis ,Humans ,Female ,Niger ,Animal Husbandry ,Pesticides ,Child ,Research Article - Abstract
Background and Objective. Environmental factors are an increasing concern for respiratory health in developing countries. The objective of this study was to investigate whether Nigerien people living in cultivated areas have more respiratory symptoms than those living in pastoral areas. Method. A cross-sectional study was conducted in 2013 in two populations during the rainy season when land is cultivated. Environmental factors including pesticide use and respiratory symptoms were collected in adults and children during face-to-face interviews. Multivariate analysis between exposures and symptoms was performed in children and in adults separately. Results. The study included 471 adults and 229 children. Overall, none of the households reported the use of pesticides for agricultural purposes. However, 87.2% reported the use of insecticides at home. Multivariate analysis showed that people living in agricultural areas compared to those in pastoral areas had an increased risk of respiratory symptoms in adults (wheezing, dyspnea, sudden shortness of breath, and cough without fever) and in children (cough without fever). The use of insecticides showed no effect on respiratory symptoms after adjustment. Conclusion. This first epidemiological study on the environment and respiratory health conducted in Niger demonstrates a significant relationship between respiratory manifestations and the agricultural characteristics of the living area. However only the effect of insecticides in the home on respiratory health was observed.
- Published
- 2016
- Full Text
- View/download PDF
9. Tobacco Addiction and HIV Infection: Toward the Implementation of Cessation Programs. ANRS CO3 Aquitaine Cohort
- Author
-
Groupe d'Epidémiologie Clinique du Sida en Aquitaine, Patrick Mercié, Jean-François Viallard, Jean-François Tessier, Fabrice Bonnet, Antoine Bénard, Geneviève Chêne, Hélène Fossoux, François Dabis, Michel Dupon, Jean-Marie Ragnaud, Mouillet, Evelyne, Epidémiologie, santé publique et développement, Université Bordeaux Segalen - Bordeaux 2 - Institut National de la Santé et de la Recherche Médicale (INSERM) - IFR99 - ISPED, CHU Bordeaux [Bordeaux], Service de médecine interne et maladies tropicales, CHU Bordeaux [Bordeaux] - Groupe hospitalier Saint-André, Service de maladies respiratoires, unité de prévention et d'aide au sevrage tabagique, Service des maladies infectieuses, CHU Bordeaux [Bordeaux] - Groupe hospitalier Pellegrin, Service de médecine interne, CHU Bordeaux [Bordeaux] - Hôpital Saint-André, and Service de médecine interne A
- Subjects
Adult ,Male ,medicine.medical_specialty ,Tobacco Use Disorders ,media_common.quotation_subject ,medicine.medical_treatment ,Population ,HIV Infections ,medicine ,Humans ,Risk factor ,Psychiatry ,education ,Depression (differential diagnoses) ,Tobacco and other drugs ,media_common ,Tobacco Use Cessation ,Depressive Disorder ,Motivation ,education.field_of_study ,biology ,Depression ,business.industry ,Addiction ,Public Health, Environmental and Occupational Health ,Tobacco Use Disorder ,Middle Aged ,biology.organism_classification ,Cross-Sectional Studies ,Infectious Diseases ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,Cohort ,Smoking cessation ,Female ,Cannabis ,business ,Demography - Abstract
International audience; In treated HIV-infected patients, mortality is now dominated by non-AIDS-related causes in which tobacco smoking is a predominant risk factor. The implementation of tobacco smoking cessation programs is therefore warranted to increase survival but should consider the specificities of this population to be successful. All outpatients consulting in May to June 2004 within the ANRS CO3 Aquitaine Cohort of HIV-infected patients were asked to complete a self-administered questionnaire including questions about tobacco and other drugs consumption, the Fagerstr?est for Nicotine Dependence (FTND), a visual scale to estimate motivation to stop smoking and the Center for Epidemiologic Studies Depression (CESD) scale. Among 509 patients included, mean age was 44 years, 74% were men, 19% were infected through injection drug use, and 257 (51%) were regular smokers (at least one cigarette per day). Among them, 60% had a medium or strong nicotine dependence (FTND = 5), 40% were motivated to quit smoking and 70% had already tried at least once. An FTND of 5 or more was more frequently reported in the 146 smokers (62%) with depressive symptoms compared to other smokers (70% versus 48%). Fifty-five regular smokers (23%) were codependent on cannabis and 31 (12%) to alcohol. Overall, only 35 (14%) regular smokers were motivated, non-codependent, without depressive symptoms, and could be proposed a standard tobacco cessation program. Depressive symptoms were highly prevalent in this representative population of HIV-infected patients. To be successful, smoking cessation interventions should be specifically built to take into account depression and codependencies in addition to nicotine dependence and motivation.
- Published
- 2007
10. Aspects psychosociaux de la prise en charge du sujet âgé
- Author
-
Jean-Pierre Clément, Jean-François Tessier, Jean-Gabriel Ouango, and David Fontanier
- Subjects
Psychology ,Humanities - Published
- 2004
11. La psychiatrie a-t-elle sa place aujourd'hui dans la prise en charge médicale du sujet âgé ? Réflexions faites au travers de l'évolution des pratiques de soins
- Author
-
Jean-marie Leger, Philippe Faugeron, Eric Charles, and Jean-François Tessier
- Subjects
Health (social science) ,Geriatrics and Gerontology ,Gerontology - Abstract
En France, l’evolution de la psychiatrie s’est faite en parallele a la prise de conscience par les pouvoirs publics de la necessite d’adapter la pratique medicale aux besoins des patients âges qui a abouti a l’emergence de la geriatrie ; les deux disciplines sont devenues complementaires. La mise en place de la sectorisation, la creation des hopitaux de jour ou de centres de traitement decentralises ont permis de traiter les malades sur leurs lieux de vie evitant l’institutionnalisation qui engendre souffrance, desinsertion et dependance. Une politique de prevention des troubles devenait possible par le biais d’un partenariat avec les soignants inseres localement. Grâce a une meilleure connaissance de la physiopathologie et de la psychopathologie du vieillard, les techniciens de sante se sont adaptes a ce type de prise en charge et ont pu lui appliquer les diverses techniques utilisees chez l’adulte. Ainsi la psychiatrie est devenue le garant de l’approche globalisante, caracteristique essentielle de toute medecine geriatrique.
- Published
- 2003
12. Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
- Author
-
George G. Zhanel, Rita Dhami, Melanie Baxter, Justin Kosar, Carlos Cervera, Neal Irfan, Rosemary Zvonar, Sergio Borgia, Jean-Francois Tessier, Gordon Dow, Robert Ariano, Maxime Dube, Michel Savoie, Matteo Bassetti, Andrew Walkty, and James A. Karlowsky
- Subjects
Ceftolozane/tazobactam ,CLEAR ,Efficacy ,Adverse effect ,Pneumonia ,Bacteraemia ,Microbiology ,QR1-502 - Abstract
ABSTRACT: Objectives: Ceftolozane/tazobactam is a cephalosporin/β-lactamase inhibitor combination with activity against Gram-negative bacilli. Here we report the use of ceftolozane/tazobactam in Canada using a national registry. Methods: The CLEAR registry uses a REDCapTM online survey to capture details associated with clinical use of ceftolozane/tazobactam. Results: Data from 51 patients treated in 2020 with ceftolozane/tazobactam are available. Infections treated included hospital-acquired bacterial pneumonia (37.3% of patients), ventilator-associated bacterial pneumonia (15.7%), bone and joint infection (11.8%), complicated intra-abdominal infection (7.8%) and complicated skin and skin-structure infection (7.8%). Moreover, 17.6% of patients had bacteraemia and 47.1% were in intensive care. Ceftolozane/tazobactam was primarily used as directed therapy for Pseudomonas aeruginosa infections (92.2% of patients). Ceftolozane/tazobactam was used because of resistance to (86.3%), failure of (11.8%) or adverse effects from (2.0%) previously prescribed antimicrobials. Ceftolozane/tazobactam susceptibility testing was performed on isolates from 88.2% of patients. Ceftolozane/tazobactam was used in combination with another antimicrobial active against Gram-negative bacilli in 39.2% of patients [aminoglycosides (15.7%), fluoroquinolones (9.8%) and colistin/polymyxin B (7.8%)]. The dosage regimen was customised in all patients based on creatinine clearance. The treatment duration was primarily >10 days (60.8% of patients), with microbiological success in 60.5% and clinical success in 64.4% of patients. Moreover, 7.8% of patients had adverse effects not requiring drug discontinuation. Conclusion: In Canada, ceftolozane/tazobactam is used as directed therapy to treat a variety of severe infections caused by multidrug-resistant P. aeruginosa. It is commonly used in combination with other antimicrobials with relatively high microbiological/clinical cure rates and an excellent safety profile.
- Published
- 2021
- Full Text
- View/download PDF
13. Indoor moulds in asthmatic patients homes
- Author
-
Jacques Lafond-Grellety, Philippe Domblides, Jean-Guy Faugère, Jean-François Tessier, Jean Mary, A. Taytard, and José-Manuel Tunon De Lara
- Subjects
immune system diseases ,law ,Environmental health ,Immunology ,Ventilation (architecture) ,Immunology and Allergy ,Asthmatic patient ,Plant Science ,complex mixtures ,respiratory tract diseases ,law.invention - Abstract
A study was conducted in 29 households with asthmatic patients in order to analyse the indoor mould concentration; an important contamination was found in both the air and the dust. Although it is known that the outdoor mould concentration in the air decreases during winter, we found that the indoor one did not vary throughout the year. Moreover, the indoor mould concentration increased during the winter in recently built houses, probably because of the poor ventilation.
- Published
- 1990
14. Long-term air pollution indicator assessment: example of black smoke in Bordeaux, France
- Author
-
Isabelle Baldi, Laurent Filleul, Philippe Quénel, Patrick Brochard, and Jean François Tessier
- Subjects
Pollution ,Epidemiology ,media_common.quotation_subject ,Air pollution ,Black smoke ,Toxicology ,medicine.disease_cause ,Risk Assessment ,Life Expectancy ,Environmental protection ,Air Pollution ,medicine ,Humans ,Longitudinal Studies ,Mortality ,media_common ,Vehicle Emissions ,Public Health, Environmental and Occupational Health ,Urban Health ,Environmental Exposure ,Environmental science ,Physical geography ,France ,Seasons ,Environmental Health ,Arithmetic mean - Abstract
The aim of the second phase of the Pollution Atmospherique et Affections Respiratoires Chroniques (PAARC) study, started in 1974, was to compare the long-term mortality between populations living in areas with different air pollution levels. In Bordeaux (France), four different areas were concerned by the study. The black smoke measures were realized between 1974 and 1981. After 1981, the stations set specifically for the study were not used any more. The purpose of this study was to estimate the evolution of air pollution in those areas between 1982 and 1997 using the measures of 12 Association de Prevention de la Pollution Atmospherique (APPA) stations located in Bordeaux city but not in the PAARC areas. The method used was divided in three phases: a correlation study between the stations of the different networks, a selection of the pertinent stations and the setting up of indicators using the arithmetic means method. Monthly means concentrations were estimated from January 1982 to December 1997. Models showed a decrease in black smoke levels whatever the area. The difference in level from one area to another, existing between the areas in 1974, was still with predicted values in 1997, but less important. Black smoke mean concentration for 1982-1997 was, respectively, 16.4 and 16.2 microg/m3, in areas 1 and 2. It was a little bit higher in area 3 with 18.9 microg/m3. Area 4 still has the highest level with 26.3 microg/m3. To conclude, this method enabled to assess different air pollution levels at different times in the four areas of the PAARC study in Bordeaux. Those levels could be used to study the impact of the air pollution on long-term mortality on populations living in the areas considered.
- Published
- 2002
15. A4-1 Consommation de tabac chez les patients infectés par le virus de l’immunodéficience humaine en Aquitaine et comparaison à la population générale
- Author
-
Jean-François Tessier, Jean-Luc Pellegrin, J. Rambeloarisoa, Antoine Bénard, H. Fossoux, Geneviève Chêne, H. Dutronc, Dabis F, and Didier Neau
- Subjects
Epidemiology ,Public Health, Environmental and Occupational Health - Published
- 2004
16. Les priorités en santé publique
- Author
-
Jean-François Tessier and François Dabis
- Subjects
medicine.medical_specialty ,Health promotion ,business.industry ,Public health ,Public Health, Environmental and Occupational Health ,medicine ,Public relations ,business ,Health policy - Published
- 2001
17. Do Subject Characteristics Modify the Effects of Particulate Air Pollution on Daily Mortality Among the Elderly?
- Author
-
Laurent Filleul, Virginie Rondeau,, Anne Cantagrel, Jean-François Dartigues, and Jean-François Tessier
- Published
- 2004
- Full Text
- View/download PDF
18. Traitement des états démentiels de l’âge
- Author
-
Jean-marie Leger and Jean-François Tessier
- Subjects
Health (social science) ,Geriatrics and Gerontology ,Gerontology - Published
- 1988
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.